Skip to main content
Fig. 1 | Critical Care

Fig. 1

From: Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands

Fig. 1

Incremental cost-effectiveness plane for procalcitonin (PCT) guidance compared with standard of care for costs during the hospitalisation episode. This incremental cost-effectiveness plane shows the impact of the use of a PCT-guided antibiotic treatment algorithm, as compared to standard of care, on the difference in in-hospital mortality and accompanying costs within this (initial) hospitalisation episode. The result is based on 10,000 bootstrap samples

Back to article page